SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review

被引:0
|
作者
Andrej Janež
Paola Fioretto
机构
[1] University Medical Centre Ljubljana,Department of Endocrinology, Diabetes and Metabolic Diseases
[2] University of Padua,Department of Medicine
[3] Hospital of Padua,Unit of Medical Clinic 3
来源
Diabetes Therapy | 2021年 / 12卷
关键词
CVOT; SGLT2 inhibitors; Type 2 diabetes; Weight loss;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2249 / 2261
页数:12
相关论文
共 50 条
  • [1] SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review
    Janez, Andrej
    Fioretto, Paola
    DIABETES THERAPY, 2021, 12 (08) : 2249 - 2261
  • [2] SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
    Thomas, Merlin C.
    Neuen, Brendon L.
    Twigg, Stephen M.
    Cooper, Mark E.
    Badve, Sunil, V
    ENDOCRINE CONNECTIONS, 2023, 12 (08)
  • [3] Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus
    Ribola, F. A.
    Cancado, F. B.
    Schoueri, J. H. M.
    De Toni, V. F.
    Medeiros, V. H. R.
    Feder, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) : 199 - 211
  • [4] The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review
    Scheen, Andre J.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2023, 18 (04) : 271 - 282
  • [5] Clinical implication of SGLT2 inhibitors in type 2 diabetes
    Kim, Go Woon
    Chung, Sung Hyun
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (08) : 957 - 966
  • [6] Clinical implication of SGLT2 inhibitors in type 2 diabetes
    Go Woon Kim
    Sung Hyun Chung
    Archives of Pharmacal Research, 2014, 37 : 957 - 966
  • [7] SGLT2 Inhibitors for Type 2 Diabetes
    Liu, Jiwen
    Lee, TaeWeon
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
  • [8] Ketoacidosis and SGLT2 Inhibitors: A Narrative Review
    Morace, Carmela
    Lorello, Giuseppe
    Bellone, Federica
    Quartarone, Cristina
    Ruggeri, Domenica
    Giandalia, Annalisa
    Mandraffino, Giuseppe
    Minutoli, Letteria
    Squadrito, Giovanni
    Russo, Giuseppina T.
    Marini, Herbert Ryan
    METABOLITES, 2024, 14 (05)
  • [9] SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice
    John Wilding
    Kevin Fernando
    Nicola Milne
    Marc Evans
    Amar Ali
    Steve Bain
    Debbie Hicks
    June James
    Philip Newland-Jones
    Dipesh Patel
    Adie Viljoen
    Diabetes Therapy, 2018, 9 : 1757 - 1773
  • [10] SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice
    Wilding, John
    Fernando, Kevin
    Milne, Nicola
    Evans, Marc
    Ali, Amar
    Bain, Steve
    Hicks, Debbie
    James, June
    Newland-Jones, Philip
    Patel, Dipesh
    Viljoen, Adie
    DIABETES THERAPY, 2018, 9 (05) : 1757 - 1773